Go Pro

Canopy Growth (CGC) Competitors

Canopy Growth logo
$0.87 -0.01 (-1.41%)
As of 12:07 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you buy Canopy Growth stock or one of its competitors? Canopy Growth's main competitors and comparable companies include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Canopy Growth compare to Aurora Cannabis?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

Aurora Cannabis has a net margin of -32.26% compared to Canopy Growth's net margin of -65.33%. Aurora Cannabis' return on equity of 4.37% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
Aurora Cannabis -32.26%4.37%3.45%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Canopy Growth had 19 more articles in the media than Aurora Cannabis. MarketBeat recorded 22 mentions for Canopy Growth and 3 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.93 beat Aurora Cannabis' score of -0.81 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
15 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aurora Cannabis
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Negative

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.4% of Canopy Growth shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Canopy Growth has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market.

Aurora Cannabis has lower revenue, but higher earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.57-$190.29M-$0.45N/A
Aurora Cannabis$247.82M1.03-$88.13M-$1.41N/A

Summary

Canopy Growth beats Aurora Cannabis on 9 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

Cronos Group has a net margin of 39.08% compared to Canopy Growth's net margin of -65.33%. Cronos Group's return on equity of 4.85% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
Cronos Group 39.08%4.85%4.62%

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.4% of Canopy Growth shares are owned by company insiders. Comparatively, 7.8% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 28.46%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Cronos Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, Canopy Growth had 19 more articles in the media than Cronos Group. MarketBeat recorded 22 mentions for Canopy Growth and 3 mentions for Cronos Group. Canopy Growth's average media sentiment score of 0.93 beat Cronos Group's score of 0.86 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
15 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cronos Group
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.57-$190.29M-$0.45N/A
Cronos Group$146.59M8.08-$9.45M$0.2016.08

Canopy Growth has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Summary

Cronos Group beats Canopy Growth on 13 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Organigram Global
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.4% of Canopy Growth shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Canopy Growth had 19 more articles in the media than Organigram Global. MarketBeat recorded 22 mentions for Canopy Growth and 3 mentions for Organigram Global. Organigram Global's average media sentiment score of 1.16 beat Canopy Growth's score of 0.93 indicating that Organigram Global is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
15 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Organigram Global
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Organigram Global has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.57-$190.29M-$0.45N/A
Organigram Global$185.07M0.73-$17.70M$0.462.08

Canopy Growth has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market.

Organigram Global has a net margin of 28.14% compared to Canopy Growth's net margin of -65.33%. Organigram Global's return on equity of -13.39% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
Organigram Global 28.14%-13.39%-8.67%

Summary

Organigram Global beats Canopy Growth on 10 of the 14 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

SNDL (NASDAQ:SNDL) and Canopy Growth (NASDAQ:CGC) are related small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SNDL$677.32M0.47-$11.29M-$0.06N/A
Canopy Growth$251.01M1.57-$190.29M-$0.45N/A

In the previous week, Canopy Growth had 21 more articles in the media than SNDL. MarketBeat recorded 22 mentions for Canopy Growth and 1 mentions for SNDL. Canopy Growth's average media sentiment score of 0.93 beat SNDL's score of 0.30 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SNDL
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Canopy Growth
15 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SNDL has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SNDL
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

3.3% of Canopy Growth shares are owned by institutional investors. 0.4% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

SNDL has a net margin of -2.36% compared to Canopy Growth's net margin of -65.33%. SNDL's return on equity of -2.01% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
SNDL-2.36% -2.01% -1.67%
Canopy Growth -65.33%-21.91%-14.34%

Summary

Canopy Growth beats SNDL on 8 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Canopy Growth (NASDAQ:CGC) and Tilray Brands (NASDAQ:TLRY) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Tilray Brands has a net margin of -13.11% compared to Canopy Growth's net margin of -65.33%. Tilray Brands' return on equity of -7.76% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-65.33% -21.91% -14.34%
Tilray Brands -13.11%-7.76%-5.59%

Tilray Brands has higher revenue and earnings than Canopy Growth. Tilray Brands is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy Growth$251.01M1.57-$190.29M-$0.45N/A
Tilray Brands$915.45M0.53-$121.40M-$1.08N/A

Canopy Growth has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 1.91, indicating that its stock price is 91% more volatile than the broader market.

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.4% of Canopy Growth shares are held by insiders. Comparatively, 0.8% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Canopy Growth had 1 more articles in the media than Tilray Brands. MarketBeat recorded 22 mentions for Canopy Growth and 21 mentions for Tilray Brands. Canopy Growth's average media sentiment score of 0.93 beat Tilray Brands' score of 0.40 indicating that Canopy Growth is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Canopy Growth
15 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tilray Brands
4 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tilray Brands has a consensus price target of $7.00, suggesting a potential upside of 96.35%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Tilray Brands
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.29

Summary

Tilray Brands beats Canopy Growth on 11 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CGC vs. The Competition

MetricCanopy GrowthPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market Cap$391.34M$12.26B$7.13B$13.27B
Dividend YieldN/A2.63%2.53%15.88%
P/E Ratio-1.94797.17273.9926.15
Price / Sales1.57751.40608.6593.06
Price / CashN/A81.7977.3851.25
Price / Book0.7710.3810.886.34
Net Income-$190.29M$2.84B$3.50B$361.18M
7 Day Performance-7.06%-1.27%-1.62%-1.17%
1 Month Performance-9.62%-5.49%-5.90%-3.40%
1 Year Performance-35.66%-3.38%9.47%3.28%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CGC
Canopy Growth
0.9529 of 5 stars
$0.87
-1.4%
N/A-36.1%$390.89M$251.01MN/A1,128
ACB
Aurora Cannabis
0.9867 of 5 stars
$4.03
+4.1%
N/A-31.9%$250.94M$247.82MN/A1,028
CRON
Cronos Group
1.376 of 5 stars
$3.33
-0.6%
$2.30
-30.9%
+20.7%$1.23B$146.59M16.65610
OGI
Organigram Global
2.5462 of 5 stars
$1.12
+6.7%
N/A-48.6%$148.09M$185.07M2.431,139
SNDL
SNDL
0.8033 of 5 stars
$1.37
flat
N/A-50.4%$352.63M$677.32MN/A2,751

Related Companies and Tools


This page (NASDAQ:CGC) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners